Recent advancements in the diagnosis and treatment of acral melanoma

Acral melanoma (AM) is the most common histologic subtype of melanoma in dark-skinned patients and is associated with a worse prognosis and a high mortality rate, largely due to the inconspicuous nature of early-stage lesions, which can lead to late diagnosis. Because of the overlapping clinical and...

Full description

Saved in:
Bibliographic Details
Published inJournal of Zhejiang University. B. Science Vol. 25; no. 2; pp. 106 - 122
Main Authors Alhaskawi, Ahmad, Ezzi, Sohaib Hasan Abdullah, Dong, Yanzhao, Zhou, Haiying, Wang, Zewei, Lai, Jingtian, Yao, Chengjun, Kota, Vishnu Goutham, Abdulla, Mohamed Hasan Abdulla Hasan, Lu, Hui
Format Journal Article
LanguageEnglish
Published Hangzhou Zhejiang University Press 01.02.2024
Springer Nature B.V
Department of Orthopedics,the First Affiliated Hospital,School of Medicine,Zhejiang University,Hangzhou 310003,China%Department of Orthopaedics,Third Xiangya Hospital,Central South University,Changsha 410013,China%Zhejiang University School of Medicine,Hangzhou 310058,China%Department of Orthopedics,the First Affiliated Hospital,School of Medicine,Zhejiang University,Hangzhou 310003,China
Alibaba-Zhejiang University Joint Research Center of Future Digital Healthcare,Zhejiang University,Hangzhou 310058,China
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Acral melanoma (AM) is the most common histologic subtype of melanoma in dark-skinned patients and is associated with a worse prognosis and a high mortality rate, largely due to the inconspicuous nature of early-stage lesions, which can lead to late diagnosis. Because of the overlapping clinical and histopathological features of AM with other forms of cutaneous melanomas, early detection of AM requires a multidisciplinary approach that integrates various diagnostic modalities, including clinical examination, dermoscopy, histopathology, molecular testing, radiological imaging, and blood tests. While surgery is the preferred method of treatment for AM, other therapeutic options may be employed based on the stage and underlying etiology of the disease. Immune checkpoint inhibitors, molecular targeted therapy, radiotherapy, chemotherapy, and oncolytic virotherapy represent promising advanced treatment options for AM. In this review, we provide an overview of the latest advancements in diagnostic and therapeutic methods for AM, highlighting the importance of early detection and the prompt, individualized management of this challenging disease.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
ISSN:1673-1581
1862-1783
DOI:10.1631/jzus.B2300221